缺血后处理对大鼠肾缺血再灌注损伤后CD105及endostatin表达的影响

李爱军; 喻俊峰; 孙德明; 蒋林涛; 张满; 易成; 汪志顺

doi:10.13201/j.issn.1001-1420.2015.05.021

缺血后处理对大鼠肾缺血再灌注损伤后CD105及endostatin表达的影响

- 1. 三峡大学人民医院(宜昌市第一人民医院)泌尿外科(湖北宜昌, 443000);
- 2. 武汉大学人民医院泌尿外科

详细信息

通讯作者: 汪志顺,E-mail:zhishun2005@126.com

中图分类号: R692

收稿日期: 2014-09-12

Effect of ischemic postconditioning on the expression of CD105and endostatin after renal ischemia-reperfusion injury in rats

- 1. Department of Urology, Renmin Hospital of Three Gorges University, First Renmin Hospital of Yichang City, Yichang, Hubei, 443000, China;
- 2. Department of Urology, Renmin Hospital of Wuhan University

More Information

Corresponding author: WANG Zhishun, E-mail: zhishun2005@126.com

Received Date: 12 September 2014

摘要

摘要: 目的：探讨缺血后处理对大鼠缺血再灌注损伤后CD105及endostatin表达的影响。方法：将雄性Wistar大鼠随机分为三组，分别为假手术组（Sham组）、缺血再灌注损伤组（IRI组）及缺血后处理组（IPO组）。采用全自动生化分析仪检测血清尿素氮（BUN）及肌酐（Cr）含量；用HE染色观察病理组织学变化；用免疫组织化学法和蛋白质印迹法（Western blot）检测肾组织中CD105及endostatin的表达。结果：IRI组血清BUN及Cr含量较Sham组明显升高，IPO组血清BUN及Cr含量介于Sham组和IRI组之间；HE染色检测发现IRI组肾小管上皮细胞坏死明显；肾小管管腔扩张，IPO组较IRI组肾小管上皮坏死明显减轻；免疫组织化学以及Western blot检测均发现CD105在Sham组表达最强，IRI组表达明显减弱，IPO组表达则介于前二者之间；endostatin在Sham组表达最弱，在IRI组最强，IPO组则稍强于Sham组而明显弱于IRI组。结论：缺血后处理能减弱缺血再灌注损伤过程中endostatin的表达量，同时增加CD105的表达，因而有助于减轻肾脏的缺血再灌注损伤。
- 缺血后处理 /
- 缺血再灌注损伤 /
- CD105 /
- endostatin /
- 大鼠
Abstract: Objective: To explore the effect of ischemic postconditioning on CD105 and endostatin after renal ischemia-reperfusion injury in Wistar rats.Method: The male Wistar rats were randomly divided into three groups:Sham group, ischemia-reperfusion injury (IRI) group, ischemic postconditioning (IPO) group. Serum blood urea nitrogen (BUN) and creatinine (Cr) were analyzed by automatic biochemical analyzer. Histopathological changes were observed by HE staining. The expression of CD105 and endostatin in kidney were checked by immunohistochemistry and Western blot.Result: Serum BUN and serum Cr in IRI group were significantly higher than those in Sham group, while serum BUN and serum Cr of IPO group were between the Sham group and IRI group. Significant necrosis of tubular epithelial cells and tubular lumen expansion could be found in hematoxylin in IRI group. Compared with IRI group, tubular necrosis significantly reduced in IPO group. The result of immunohistochemistry showed that the expression of CD105 was the strongest in Sham group, and significantly decreased in the IRI group, and was between them in IPO group, while the expression of endostatin was the weakest in the Sham group, the strongest in IRI group, and IPO group's expression was slightly stronger than the Sham group's but was significantly weaker than IRI group's. Western blot test further supported the results of immunohistochemistry.Conclusion: Ischemic postconditioning could reduce the expression of endostatin after IRI, and enhance the expression of CD105, which helps to reduce kidney injury.
- ischemic postconditioning /
- ischemia-reperfusion injury /
- CD105 /
- endostatin /
- rats

HTML全文

参考文献(18)

[1]	Serviddio G, Romano A D, Gesualdo L, et al.Postconditioning is an effective strategy to reduce renal ischaemia/reperfusion injury[J].Nephrol Dial Transplant, 2008, 23:1504-1512.
[2]	Jiang S H, Liu C F, Zhang X L, et al.Renal protection by delayed ischaemic preconditioning is associated with inhibition of the inflammatory response and NF-kappaB activation[J].Cell Biochem Funct, 2007, 25:335-343.
[3]	Ogawa T, Mimura Y, Hiki N, et al.Ischemic preconditioning ameliorates functional disturbance and impaired renal perfusion in rat ischemia reperfused kidneys[J].Clin Exp Pharlmacol Physiol, 2000, 27(12):467
[4]	Lee H T, Emala C W.Protective effects of renal ischemic preconditioning and adenosine pretreatment:role of A(1) and A(3) receptors[J].Am J Physiol Renal Physiol, 2000, 278(3):380-387.
[5]	Jefayri M K, Grace P A, Mathie R T.Attenuation of reperfusion injury by renal ischaemic preconditioning:the role Of nitric oxide[J].BJU Int, 2000, 85(9):1007-1013.
[6]	Zhao Z Q, Corvera J S, Halkos M E, et al.Inhibition of myocardial injury by ischemic postconditioning during reperfusion:comparison with ischemic preconditioning[J].Am J Physiol Heart Circ Physiol, 2003, 285:H579-H588.
[7]	Yuan Y, Guo Q, Ye Z, et al.Ischemic postconditioning protects brain from ischemia/reperfusion injury by attenuating endoplasmic reticulum stress-induced apoptosis through PI3K-Akt pathway[J].Brain Res, 2011, 1367:85-93.
[8]	Sun K, Liu ZS, Sun Q.Role of mitochondria in cell apoptosis during hepatic ischemia-reperfusion injury and protective effect of ischemic postconditioning[J].World J Gastroenterol, 2004, 10:1934-1938.
[9]	Chen H, Xing B, Liu X, et al.Ischemic postconditioning inhibits apoptosis after renal ischemia/reperfusion injury in rat[J].Transpl Int, 2008, 21:364-371.
[10]	Feitoza C Q, Camara N O, Pinheiro H S, et al.Cyclooxygenase 1and/or 2blockade ameliorates the renal tissue damage triggered by ischemia and reperfusion injury[J].Int Immunopharmacol, 2005, 5:79.
[11]	Bonegio R, Lieberthal W.Role of apoptosis in the pathogenesis of acute renal failure[J].Curr Opin Nephrol Hypertens, 2002, 11:301.
[12]	Daemen M A, de Vries B, Buurman W A.Apoptosis and inflammation in renal reperfusion injury[J].Transplantation, 2002, 73:1693.
[13]	Daemen M A, van't Veer C, Denecker G, et al.Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation[J].J Clin Invest, 1999, 104:541.
[14]	Zhang W L, Zhao Y L, Liu X M, et al.Protective role of mitochondrial K-ATP channel and mitochondrial membrane transport pore in rat kidney ischemic postconditioning[J].Chin Med J(Engl), 2011, 124:2191.
[15]	Wang W, Tang T, Zhang P, et al.Postconditioning attenuates renal ischemia-reperfusion injury by preventing DAF down-regulation[J].J Urol, 2010, 183:2424.
[16]	Dallas N A, Samuel S, Xia L, et al.Endoglin(CD105):a marker of tumor vasculature and potential target for therapy[J].J Clin Cancer Res, 2008, 14(7):1931-1937.
[17]	Duff S E, Li C, Garland J M, et al.CD105is important for angiogenesis:evidence and potential applications[J].FASEB J, 2003, 17:984.
[18]	Lastres P, Martin-Perez J, Langa C, et al.Phosphorylation of the human-transforming-growth-factor-betabinding protein endoglin[J].Biochem J, 1994, 301(Pt3):765.